We are monitoring the impact of COVID-19 & Recession alarm on Latin America Prostate Cancer Market Get in touch with us for detailed analysis Know More
Share on

Latin America Prostate Cancer Market Research Report - Segmented By Diagnostic Techniques, Surgery, Radiation Therapy, Chemotherapy and Country (Mexico, Brazil, Argentina, Chile and Rest of Latin America) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2022 to 2027)

Published: January, 2022
ID: 1540
Pages: 145

Latin America Prostate Cancer Market Size (2022 to 2027)

As per our report, the Latin America Prostate Cancer Market size was valued at USD 6.98 billion in 2022. This value is further estimated to be worth USD 11.41 billion by 2027, growing at a CAGR of 10.32% during the forecast period.

A few of the significant factors driving the growth of the Latin American prostate cancer market include an increase in the geriatric population, an increase in the prevalence of prostate cancer, a surge in generic products, an increase in public awareness about prostate cancer treatment, increased R&D investment by drug innovators, potent emerging pipeline drugs, and the availability of new prostate cancer treatments. Other factors that contribute to the market's growth include an increase in demand for prostate cancer therapy and management and an increase in the use of hormonal treatments in non-metastatic castration-resistant and metastatic hormone naive prostate cancer settings.

Furthermore, the developing economies' untapped potential offers profitable chances for economic expansion. The market growth is also is expected to be fuelled by the adoption of innovative technologies in screening and diagnostic testing. For example, Multiparametric MRI (mp-MRI) can considerably increase tumor identification while confirming whether tissue biopsy is required. Furthermore, manufacturers in the market are spending research to create treatments for the treatment of such malignancies.

In addition, due to the expiration of patents on major existing products throughout the forecast period, many generic products are likely to join the market. As a result, growth is expected to be fueled by these factors. For patients with breast or gastric cancer who are candidates for targeted therapy, Roche has released the VENTANA HER2 Dual ISH companion diagnostic test. The VENTANA HER2 Dual ISH DNA Probe Cocktail test on the BenchMark IHC/ISH equipment provides an improved bright field assay that is fully automated. In the male population, prostate cancer is the second most frequent type of cancer.

The growth of the Latin American prostate cancer market is likely to be hampered by long treatment durations and low demand for prostate cancer treatment medications in this nation. In addition, the market is projected to be hindered by the high cost of prostate cancer medications and the low success rate of clinical trials.

This research report on the Latin American prostate cancer market has been segmented and sub-segmented into the following categories.

By Diagnostic Techniques: 

  • Digital Rectal Exam (DRE)
  • Prostate-Specific Antigen Test (PSA)

By Surgery: 

  • Radical Prostatectomy
  • Orchidectomy
  • Trans Urethral Resection (TUR)

By Radiation Therapy: 

  • External Beam Radiation Therapy
  • Brachytherapy

By Chemotherapy: 

  • Docetaxel
  • Etoposide
  • Vinblastine
  • Carboplatin
  • Vinorelbine

By Country: 

  • Mexico
  • Brazil
  • Argentina
  • Chile
  • Rest of Latin America

The Brazilian market for prostate cancer treatment in Latin America is predicted to develop significantly due to the rising incidence of cancer in the country, facilitating demand for cancer treatment and growing approval of novel products for cancer treatment. To increase their product portfolio and develop novel therapies for cancer treatment, pharmaceutical companies in the oncology device market are relying on inorganic growth strategies such as acquisitions and collaborations. This increase is attributed to an aging population, increased smoking, obesity, poor dietary habits, rising prostate cancer prevalence, increased uptake of hormonal agents, and increased demand for prostate cancer treatment and management. Latin America has to develop policies that allow disadvantaged people access to health care and next-generation anti-cancer medications, such as high-cost targeted therapies, to increase survival rates. In addition, cancer clinical research must be geared toward developing cancer biomarkers that are tailored to specific populations of various ethnicities, allowing for better patient outcomes.

KEY MARKET PLAYERS:

Companies such as Sanofi S.A, GlaxoSmithKline, AstraZeneca, AbbVie, Varian Medical Systems, Elekta, Theragenics, Pfizer, Novartis, Roche, Bayer, Johnson & Johnson, Abbott Laboratories, and Genentech are currently dominating the Latin American prostate cancer market.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Research Phases                      

                                2.2.1 Secondary Research            

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling     

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                             

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 Diagnostic Techniques                           

                                5.1.1 Introduction           

                                5.1.2 Digital Rectal Exam (DRE)  

                                5.1.3 Prostate Specific Antigen Test (PSA)            

                                5.1.4 Y-o-Y Growth Analysis, By Product

                                5.1.5 Market Attractiveness Analysis, By Product               

                                5.1.6 Market Share Analysis, By Product                

                5.2 Surgery                        

                                5.2.1 Introduction           

                                5.2.2 Radical Prostatectomy       

                                5.2.3 Orchidectomy        

                                5.2.4 Trans Urethral Resection (TUR)      

                                5.2.5 Y-o-Y Growth Analysis, By Type      

                                5.2.6 Market Attractiveness Analysis, By Type     

                                5.2.7 Market Share Analysis, By Type      

                5.3 Radiation Therapy                   

                                5.3.1 Introduction           

                                5.3.2 External Beam Radiation Therapy  

                                                5.3.2.1 3D Conformal Radiation Therapy

                                                5.3.2.2 Intensity Modulated Radiation Therapy

                                                5.3.2.3 Stereotactic Body Radiation Therapy

                                                5.3.2.4 Proton Beam Radiation Therapy

                                5.3.3 Brachytherapy      

                                                5.3.3.1 Permanent Brachytherapy

                                                5.3.3.2 Temporary Brachytherapy

                                5.3.4 Y-o-Y Growth Analysis, By Application         

                                5.3.5 Market Attractiveness Analysis, By Application        

                                5.3.6 Market Share Analysis, By Application         

                5.4 Chemotherapy                         

                                5.4.1 Introduction           

                                5.4.2 Docetaxel

                                5.4.3 Etoposide

                                5.4.4 Vinblastine             

                                5.4.5 Carboplatin             

                                5.4.6 Vinorelbine            

                                5.4.7 Y-o-Y Growth Analysis, By Disease Indications          

                                5.4.8 Market Attractiveness Analysis, By Disease Indications        

                                5.4.9 Market Share Analysis, By Disease Indications         

6. Geographical Analysis                                              

                6.1 Introduction                              

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Diagnostic Techniques

                                                6.1.3.3 By Surgery

                                                6.1.3.4 By Radiation Therapy

                                                6.1.3.5 By Chemotherapy

                                6.1.4 Market Attractiveness Analysis      

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Diagnostic Techniques

                                                6.1.4.3 By Surgery

                                                6.1.4.4 By Radiation Therapy

                                                6.1.4.5 By Chemotherapy

                                6.1.5 Market Share Analysis        

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Diagnostic Techniques

                                                6.1.5.3 By Surgery

                                                6.1.5.4 By Radiation Therapy

                                                6.1.5.5 By Chemotherapy

                6.2 Brazil                             

                6.3 Mexico                         

                6.4 Rest of Latin America                             

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental      

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry      

8.Market Leaders' Analysis                                          

                8.1 Sanofi S.A                    

                                8.1.1 Overview

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 GlaxoSmithKline                      

                8.3 AstraZeneca               

                8.4 AbbVie                         

                8.5 Varian Medical Systems                        

                8.6 Elekta                           

                8.7 Theragenics               

                8.8 Pfizer                            

                8.9 Novartis                       

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                        

                9.3 Agreements, collaborations and Joint Ventures                          

                9.4 New Product Launches                          

10.Market Outlook and Investment Opportunities                                           

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  1. Latin America Prostate Cancer Market, By Diagnostic Techniques , From 2022 - 2027 (USD Million)
  2. Latin America Digital Rectal Exam (DRE) Market, By Region, From 2022 - 2027 (USD Million)
  3. Latin America Prostate Specific Antigen Test (PSA) Market, By Region, From 2022 - 2027 (USD Million)
  4. Latin America Prostate Cancer Market, By Surgery, From 2022 - 2027 (USD Million)
  5. Latin America Radical Prostatectomy Market, By Region, From 2022 - 2027 (USD Million)
  6. Latin America Orchidectomy Market, By Region, From 2022 - 2027 (USD Million)
  7. Latin America Trans Urethral Resection (TUR) Market, By Region, From 2022 - 2027 (USD Million)
  8. Latin America Prostate Cancer Market, By Radiation Therapy, From 2022 - 2027 (USD Million)
  9. Latin America External Beam Radiation Therapy Market, By Region, From 2022 - 2027 (USD Million)
  10. Latin America Brachytherapy Market, By Region, From 2022 - 2027 (USD Million)
  11. Latin America Prostate Cancer Market, By ChemoTherapy, From 2022 - 2027 (USD Million)
  12. Latin America Docetaxel Market, By Region, From 2022 - 2027 (USD Million)
  13. Latin America Etoposide Market, By Region, From 2022 - 2027 (USD Million)
  14. Latin America Vinblastine Market, By Region, From 2022 - 2027 (USD Million)
  15. Latin America Carboplatin Market, By Region, From 2022 - 2027 (USD Million)
  16. Latin America Vinorelbine Market, By Region, From 2022 - 2027 (USD Million)
  17. Brazil Prostate Cancer Market, By Diagnostic Techniques , From 2022 - 2027 (USD Million)
  18. Brazil Prostate Cancer Market, By Surgery, From 2022 - 2027 (USD Million)
  19. Brazil Prostate Cancer Market, By Radiation Therapy, From 2022 - 2027 (USD Million)
  20. Brazil Prostate Cancer Market, By ChemoTherapy, From 2022 - 2027 (USD Million)
  21. Argentina Prostate Cancer Market, By Diagnostic Techniques , From 2022 - 2027 (USD Million)
  22. Argentina Prostate Cancer Market, By Surgery, From 2022 - 2027 (USD Million)
  23. Argentina Prostate Cancer Market, By Radiation Therapy, From 2022 - 2027 (USD Million)
  24. Argentina Prostate Cancer Market, By ChemoTherapy, From 2022 - 2027 (USD Million)
  25. Mexico Prostate Cancer Market, By Diagnostic Techniques , From 2022 - 2027 (USD Million)
  26. Mexico Prostate Cancer Market, By Surgery, From 2022 - 2027 (USD Million)
  27. Mexico Prostate Cancer Market, By Radiation Therapy, From 2022 - 2027 (USD Million)
  28. Mexico Prostate Cancer Market, By ChemoTherapy, From 2022 - 2027 (USD Million)
  29. Rest of Latin America Prostate Cancer Market, By Diagnostic Techniques , From 2022 - 2027 (USD Million)
  30. Rest of Latin America Prostate Cancer Market, By Surgery, From 2022 - 2027 (USD Million)
  31. Rest of Latin America Prostate Cancer Market, By Radiation Therapy, From 2022 - 2027 (USD Million)
  32. Rest of Latin America Prostate Cancer Market, By ChemoTherapy, From 2022 - 2027 (USD Million)
  33. Latin America Prostate Cancer Market, By External Beam Radiation Therapy, From 2022 - 2027 (USD Million)
  34. Latin America 3D Conformal Radiation Therapy Market, By Region, From 2022 - 2027 (USD Million)
  35. Latin America Intensity Modulated Radiation Therapy Market, By Region, From 2022 - 2027 (USD Million)
  36. Latin America Stereotactic Body Radiation Therapy Market, By Region, From 2022 - 2027 (USD Million)
  37. Latin America Proton Beam Radiation Therapy Market, By Region, From 2022 - 2027 (USD Million)
  38. Brazil Prostate Cancer Market, By External Beam Radiation Therapy, From 2022 - 2027 (USD Million)
  39. Argentina Prostate Cancer Market, By External Beam Radiation Therapy, From 2022 - 2027 (USD Million)
  40. Mexico Prostate Cancer Market, By External Beam Radiation Therapy, From 2022 - 2027 (USD Million)
  41. Latin America Prostate Cancer Market, By Brachytherapy, From 2022 - 2027 (USD Million)
  42. Latin America Permanent Brachytherapy Market, By Region, From 2022 - 2027 (USD Million)
  43. Latin America Temporary Brachytherapy Market, By Region, From 2022 - 2027 (USD Million)
  44. Brazil Prostate Cancer Market, By Brachytherapy, From 2022 - 2027 (USD Million)
  45. Argentina Prostate Cancer Market, By Brachytherapy, From 2022 - 2027 (USD Million)
  46. Mexico Prostate Cancer Market, By Brachytherapy, From 2022 - 2027 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

excel
$

2875


pdf excel
$

3220


pdf excel powerbi
$

4600


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2875

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample